Acne-induced Post-inflammatory Hyperpigmentation: From Grading to Treatment
DOI:
https://doi.org/10.2340/actadv.v105.42925Keywords:
acne, post-inflammatory hyperpigmentation, treatments, retinoidsAbstract
Acne-induced post-inflammatory hyperpigmentation (AI-PIH) can occur without any visible clinical evidence of significant inflammation, even in patients with mild to moderate acne. Currently, visual assessment is the main criterion for evaluating the severity of PIH, including that of AI-PIH in daily clinical practice. Treatment indications are lacking. This work provides an easy-to-use AI-PIH severity grading tool for daily clinical practice as well as indications on how to prevent and treat AI-PIH using currently available treatment options. Five experts in acne provided a short overview concerning the epidemiology and physiopathology of AI-PIH, developed an AI-PIH severity grading tool, and proposed preventive measures as well as an AI-PIH treatment algorithm. Only a small number of epidemiological data on AI-PIH are available, confirming that the condition is mainly observed in patients with Phototypes IV to VI. The physiopathology of AI-PIH is still not completely understood. Innate immunity, Cutibacterium acnes, and external factors such as UV radiation, visible light, and air pollution play a role in its development. An easy-to-use AI-PIH severity grading tool (Acne PIgmentation Grading) allows quick assessment of acne severity during the consultation, and, in addition to proposed preventive measures, a treatment algorithm is proposed according to AI-PH severity. Patient education remains key. Providing an AI-PIH severity assessment tool as well as preventive and treatment recommendations may help to manage AI-PIH more efficiently.
Downloads
References
Tan JK, Bhate K. A global perspective on the epidemiology of acne. Br J Dermatol 2015; 172: 3–12.
https://doi.org/10.1111/bjd.13462 DOI: https://doi.org/10.1111/bjd.13462
Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol 2017; 77: 591–605.
https://doi.org/10.1016/j.jaad.2017.01.035 DOI: https://doi.org/10.1016/j.jaad.2017.01.035
Anvery N, Christensen RE, Dirr MA. Management of post-inflammatory hyperpigmentation in skin of color: a short review. J Cosmet Dermatol 2022; 21: 1837–1840.
https://doi.org/10.1111/jocd.14916 DOI: https://doi.org/10.1111/jocd.14916
Sangha AM. Managing post-inflammatory hyperpigmentation in patients with acne. J Clin Aesthet Dermatol 2021; 14: S24–S26.
Ludwig RJ, von Stebut E. Entzündliche Dermatosen auf pigmentierter Haut. Dermatologie (Heidelb) 2023; 74: 84–89.
https://doi.org/10.1007/s00105-022-05096-0 DOI: https://doi.org/10.1007/s00105-022-05096-0
Tan MG, Kim WB, Jo CE, Nabieva K, Kirshen C, Ortiz AE. Topical treatment for postinflammatory hyperpigmentation: a systematic review. J Dermatolog Treat 2022; 33: 2518–2526.
https://doi.org/10.1080/09546634.2021.1981814 DOI: https://doi.org/10.1080/09546634.2021.1981814
Akinboro AO, Ezejiofor OI, Olanrewaju FO, Oripelaye MM, Olabode OP, Ayodele OE, et al. The impact of acne and facial post-inflammatory hyperpigmentation on quality of life and self-esteem of newly admitted Nigerian undergraduates. Clin Cosmet Investig Dermatol 2018; 11: 245–252.
https://doi.org/10.2147/CCID.S158129 DOI: https://doi.org/10.2147/CCID.S158129
Swearingen A, Olagun-Samuel C, Nagler AR, Adotama P. Assessing the inclusion of postinflammatory hyperpigmentation outcomes in acne vulgaris clinical trials. J Am Acad Dermatol 2025; 92: 323–324.
https://doi.org/10.1016/j.jaad.2024.10.004 DOI: https://doi.org/10.1016/j.jaad.2024.10.004
Shah SK, Alexis AF. Acne in skin of color: practical approaches to treatment. J Dermatolog Treat 2010; 21: 206–211.
https://doi.org/10.3109/09546630903401496 DOI: https://doi.org/10.3109/09546630903401496
Kang SJ, Davis SA, Feldman SR, McMichael AJ. Dyschromia in skin of color. J Drugs Dermatol 2014; 13: 401–406.
Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis 2007; 80: 387–394.
Abad-Casintahan F, Chow SK, Goh CL, Kubba R, Hayashi N, Noppakun N, et al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol 2016; 43: 826–828.
https://doi.org/10.1111/1346-8138.13263 DOI: https://doi.org/10.1111/1346-8138.13263
Abanmi A, Al-Enezi M, Al Hammadi A, Galadari I, Kibbi AG, Zimmo S. Survey of acne-related post-inflammatory hyperpigmentation in the Middle East. J Dermatolog Treat 2019; 30: 578–581.
https://doi.org/10.1080/09546634.2018.1542807 DOI: https://doi.org/10.1080/09546634.2018.1542807
Perkins AC, Cheng CE, Hillebrand GG, Miyamoto K, Kimball AB. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol 2011; 25: 1054–1060.
https://doi.org/10.1111/j.1468-3083.2010.03919.x DOI: https://doi.org/10.1111/j.1468-3083.2010.03919.x
Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol 2002; 46: S98–S106.
https://doi.org/10.1067/mjd.2002.120791 DOI: https://doi.org/10.1067/mjd.2002.120791
Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, Taylor S, et al. The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. Am J Clin Dermatol 2021; 22: 829–836.
https://doi.org/10.1007/s40257-021-00633-4 DOI: https://doi.org/10.1007/s40257-021-00633-4
Passeron T, Lim HW, Goh CL, Kang HY, Ly F, Morita A, et al. Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel. J Eur Acad Dermatol Venereol 2021; 35: 1460–1409.
https://doi.org/10.1111/jdv.17242 DOI: https://doi.org/10.1111/jdv.17242
Burns EM, Ahmed H, Isedeh PN, Kohli I, Van Der Pol W, Shaheen A, et al. Ultraviolet radiation, both UVA and UVB, influences the composition of the skin microbiome. Exp Dermatol 2019; 28: 136–141.
https://doi.org/10.1111/exd.13854 DOI: https://doi.org/10.1111/exd.13854
Poli F. Acne on pigmented skin. Int J Dermatol 2007; 46:
S39–S41.
https://doi.org/10.1111/j.1365-4632.2007.03463.x DOI: https://doi.org/10.1111/j.1365-4632.2007.03463.x
Goh CL, Noppakun N, Micali G, Azizan NZ, Boonchai W, Chan Y, et al. Meeting the challenges of acne treatment in Asian patients: a review of the role of dermocosmetics as adjunctive therapy. J Cutan Aesthet Surg 2016; 9: 85–92.
https://doi.org/10.4103/0974-2077.184043 DOI: https://doi.org/10.4103/0974-2077.184043
Maghfour J, Olayinka J, Hamzavi IH, Mohammad TF. A Focused review on the pathophysiology of post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res 2022; 35: 320–327.
https://doi.org/10.1111/pcmr.13038 DOI: https://doi.org/10.1111/pcmr.13038
Tanghetti EA. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol 2013; 6: 27–35.
Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol 2010; 3: 20–31.
Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003; 121: 20–27.
https://doi.org/10.1046/j.1523-1747.2003.12321.x DOI: https://doi.org/10.1046/j.1523-1747.2003.12321.x
Al-Qarqaz F, Bodoor K, Baba A, Al-Yousef A, Muhaidat J, Alshiyab D. Post-acne hyperpigmentation: evaluation of risk factors and the use of artificial neural network as a predictive classifier. Dermatol Reports 2021; 13: 8223.
https://doi.org/10.4081/dr.2021.8223 DOI: https://doi.org/10.4081/dr.2021.8223
Markiewicz E, Karaman-Jurukovska N, Mammone T, Idowu OC. Post-inflammatory hyperpigmentation in dark skin: molecular mechanism and skincare implications. Clin Cosmet Investig Dermatol 2022; 15: 2555–2565.
https://doi.org/10.2147/CCID.S385162 DOI: https://doi.org/10.2147/CCID.S385162
Adalatkhah H, Sadeghi Bazargani H. The association between melasma and postinflammatory hyperpigmentation in acne patients. Iran Red Crescent Med J 2013; 15: 400–403.
https://doi.org/10.5812/ircmj.5358 DOI: https://doi.org/10.5812/ircmj.5358
Cayce KA, McMichael AJ, Feldman SR. Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs 2004; 16: 401–406, 413–416; quiz 417.
Dreno B, Gollnick HP, Kang S, Thiboutot D, Bettoli V, Torres V, et al. Understanding innate immunity and inflammation in acne: implications for management. J Eur Acad Dermatol Venereol 2015; 29: S3–S11.
https://doi.org/10.1111/jdv.13190 DOI: https://doi.org/10.1111/jdv.13190
Koike S, Yamasaki K. Melanogenesis connection with innate immunity and toll-like receptors. Int J Mol Sci 2020; 21: 9769.
https://doi.org/10.3390/ijms21249769 DOI: https://doi.org/10.3390/ijms21249769
Yadalla H, Sacchidanand S. Post acne hyperpigmentation: a brief review. Our Dermatology Online 2011; 2: 230–231.
Regazzetti C, De Donatis GM, Ghorbel HH, Cardot-Leccia N, Ambrosetti D, Bahadoran P, et al. Endothelial cells promote pigmentation through endothelin receptor B activation. J Invest Dermatol 2015; 135: 3096–3104.
https://doi.org/10.1038/jid.2015.332 DOI: https://doi.org/10.1038/jid.2015.332
Wang RF, Ko D, Friedman BJ, Lim HW, Mohammad TF. Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders. J Am Acad Dermatol 2023; 88: 271–288.
https://doi.org/10.1016/j.jaad.2022.01.051 DOI: https://doi.org/10.1016/j.jaad.2022.01.051
Goh CL, Abad-Casintahan F, Chow SK, Kubba R, Miyachi Y, Noppakun N, et al. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts. J Dermatol 2014; 41: 1106–1108.
https://doi.org/10.1111/1346-8138.12667 DOI: https://doi.org/10.1111/1346-8138.12667
Savory SA, Agim NG, Mao R, Peter S, Wang C, Maldonado G, et al. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris. J Am Acad Dermatol 2014; 70: 108–114.
https://doi.org/10.1016/j.jaad.2013.09.017 DOI: https://doi.org/10.1016/j.jaad.2013.09.017
Callender VD, Young CM, Kindred C, Taylor SC. Efficacy and safety of clindamycin phosphate 1.2% and tretinoin 0.025% gel for the treatment of acne and acne-induced post-inflammatory hyperpigmentation in patients with skin of color. J Clin Aesthet Dermatol 2012; 5: 25–32.
Grimes P, Callender V. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis 2006; 77: 45–50.
Shokeen D. Postinflammatory hyperpigmentation in patients with skin of color. Cutis 2016; 97: E9–E11.
Taylor S, Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, et al. Treatment recommendations for acne-associated hyperpigmentation: results of the Delphi consensus process and a literature review. J Am Acad Dermatol 2023; 89: 316–323.
https://doi.org/10.1016/j.jaad.2023.02.053 DOI: https://doi.org/10.1016/j.jaad.2023.02.053
Fatima S, Braunberger T, Mohammad TF, Kohli I, Hamzavi IH. The role of sunscreen in melasma and postinflammatory hyperpigmentation. Indian J Dermatol 2020; 65: 5–10.
https://doi.org/10.4103/ijd.IJD_295_18 DOI: https://doi.org/10.4103/ijd.IJD_295_18
Roberts WE. Pollution as a risk factor for the development of melasma and other skin disorders of facial hyperpigmentation: is there a case to be made? J Drugs Dermatol 2015; 14: 337–341.
Kashetsky N, Feschuk A, Pratt ME. Post-inflammatory hyperpigmentation: a systematic review of treatment outcomes. J Eur Acad Dermatol Venereol 2024; 38: 470–479.
https://doi.org/10.1111/jdv.19566 DOI: https://doi.org/10.1111/jdv.19566
Ko D, Wang RF, Ozog D, Lim HW, Mohammad TF. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation. J Am Acad Dermatol 2023; 88: 291–320.
https://doi.org/10.1016/j.jaad.2021.12.065 DOI: https://doi.org/10.1016/j.jaad.2021.12.065
Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E. Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice. Am J Clin Dermatol 2022; 23: 69–81.
https://doi.org/10.1007/s40257-021-00643-2 DOI: https://doi.org/10.1007/s40257-021-00643-2
Chiang C, Ward M, Gooderham M. Dermatology: how to manage acne in skin of colour. Drugs Context 2022; 11: 2021-10-19.
https://doi.org/10.7573/dic.2021-10-9 DOI: https://doi.org/10.7573/dic.2021-10-9
Chaowattanapanit S, Silpa-Archa N, Kohli I, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: treatment options and prevention. J Am Acad Dermatol 2017; 77: 607–621.
https://doi.org/10.1016/j.jaad.2017.01.036 DOI: https://doi.org/10.1016/j.jaad.2017.01.036
Alexis A, Del Rosso JQ, Forman S, Martorell A, Browning J, Laquer V, et al. Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation. Int J Dermatol 2024; 63: 806–815.
https://doi.org/10.1111/ijd.17189 DOI: https://doi.org/10.1111/ijd.17189
DuBois J, Ong GCW, Petkar G, Almeida LMC, Chavda R, Kerrouche N, et al. Patient-reported outcomes in acne patients with skin of color using adapalene 0.3%-benzoyl peroxide 2.5%: a prospective real-world study. J Drugs Dermatol 2019; 18: 514.
da Rocha MAD, Fierro-Arias L, Cohen Sabban EN, Castillo RS, Chavda R, Almeida LM. Acne characteristics in Latin American patients and the potential role of trifarotene. Int J Dermatol 2023; 62: 1176–1185.
https://doi.org/10.1111/ijd.16754 DOI: https://doi.org/10.1111/ijd.16754
Mahjoub TT, Milibary HH. Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: a review. J Cosmet Dermatol 2023; 22: 1157–1162.
https://doi.org/10.1111/jocd.15561 DOI: https://doi.org/10.1111/jocd.15561
Gaćina K, Krstanović Ćosić A. The use of tranexamic acid in dermatology. Acta Clin Croat 2023; 62: 368–372.
https://doi.org/10.20471/acc.2023.62.02.16 DOI: https://doi.org/10.20471/acc.2023.62.02.16
Sobhan M, Talebi-Ghane E, Poostiyan E. A comparative study of 20% azelaic acid cream versus 5% tranexamic acid solution for the treatment of postinflammatory hyperpigmentation in patients with acne vulgaris: a single-blinded randomized clinical trial. J Res Med Sci 2023; 28: 18.
https://doi.org/10.4103/jrms.jrms_443_22 DOI: https://doi.org/10.4103/jrms.jrms_443_22
Aggarwal I, Rossi M, Puyana C, Tsoukas M. Review of fractional nonablative lasers for the treatment of dermatologic conditions in darker skin phototypes. Dermatol Surg 2024; 50: 459–466.
https://doi.org/10.1097/DSS.0000000000004111 DOI: https://doi.org/10.1097/DSS.0000000000004111
Teymour S, Kania B, Lal K, Goldberg D. Energy-based devices in the treatment of acne scars in skin of color. J Cosmet Dermatol 2023; 22: 1177–1184.
https://doi.org/10.1111/jocd.15572 DOI: https://doi.org/10.1111/jocd.15572
Sowash M, Alster T. Review of laser treatments for post-inflammatory hyperpigmentation in skin of color. Am J Clin Dermatol 2023; 24: 381–396.
https://doi.org/10.1007/s40257-023-00759-7 DOI: https://doi.org/10.1007/s40257-023-00759-7
Wu X, Wang X, Cen Q, Xi W, Shang Y, Zhang Z, et al. Intense pulsed light therapy improves acne-induced post-inflammatory erythema and hyperpigmentation: a retrospective study in Chinese patients. Dermatol Ther (Heidelb) 2022; 12: 1147–1156.
https://doi.org/10.1007/s13555-022-00719-9 DOI: https://doi.org/10.1007/s13555-022-00719-9
Alster TS, Tanzi EL. Laser surgery in dark skin. Skinmed 2003; 2: 80–85.
https://doi.org/10.1111/j.1540-9740.2003.01664.x DOI: https://doi.org/10.1111/j.1540-9740.2003.01664.x
Battle EF Jr, Hobbs LM. Laser therapy on darker ethnic skin. Dermatol Clin 2003; 21: 713–723.
https://doi.org/10.1016/S0733-8635(03)00086-X DOI: https://doi.org/10.1016/S0733-8635(03)00086-X
Mohamed Ali BM, Gheida SF, El Mahdy NA, Sadek SN. Evaluation of salicylic acid peeling in comparison with topical tretinoin in the treatment of postinflammatory hyperpigmentation. J Cosmet Dermatol 2017; 16: 52–60.
https://doi.org/10.1111/jocd.12301 DOI: https://doi.org/10.1111/jocd.12301
Sarkar R, Parmar NV, Kapoor S. Treatment of postinflammatory hyperpigmentation with a combination of glycolic acid peels and a topical regimen in dark-skinned patients: a comparative study. Dermatol Surg 2017; 43: 566–573.
https://doi.org/10.1097/DSS.0000000000001007 DOI: https://doi.org/10.1097/DSS.0000000000001007
Kircik LH. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. J Drugs Dermatol 2011; 10: 586–590.
Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147: 20–31.
https://doi.org/10.1046/j.1365-2133.2002.04834.x DOI: https://doi.org/10.1046/j.1365-2133.2002.04834.x
Shucheng H, Zhou X, Du D, Li J, Yu C, Jiang X. Effects of 15% azelaic acid gel in the management of post-inflammatory erythema and post-inflammatory hyperpigmentation in acne vulgaris. Dermatol Ther (Heidelb) 2024; 14: 1293–1314.
https://doi.org/10.1007/s13555-024-01176-2 DOI: https://doi.org/10.1007/s13555-024-01176-2
Kaewsanit T, Chakkavittumrong P, Waranuch N. Clinical comparison of topical 2.5% benzoyl peroxide plus 5% niacinamide to 2.5% benzoyl peroxide alone in the treatment of mild to moderate facial acne vulgaris. J Clin Aesthet Dermatol 2021; 14: 35–41.
Pisano L, Turco M, Supuran CT. Biomedical applications of tyrosinases and tyrosinase inhibitors. Enzymes 2024; 56: 261–280.
https://doi.org/10.1016/bs.enz.2024.05.005 DOI: https://doi.org/10.1016/bs.enz.2024.05.005
Searle T, Al-Niaimi F, Ali FR. The top 10 cosmeceuticals for facial hyperpigmentation. Dermatol Ther 2020; 33: e14095.
https://doi.org/10.1111/dth.14095 DOI: https://doi.org/10.1111/dth.14095
Roggenkamp D, Dlova N, Mann T, Batzer J, Riedel J, Kausch M, et al. Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol). Int J Cosmet Sci 2021; 43: 292–301.
https://doi.org/10.1111/ics.12694 DOI: https://doi.org/10.1111/ics.12694
Nast A, Dreno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne: update 2016 – short version. J Eur Acad Dermatol Venereol 2016; 30: 1261–1268.
https://doi.org/10.1111/jdv.13776 DOI: https://doi.org/10.1111/jdv.13776
Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74: 945–973.e33.
https://doi.org/10.1016/j.jaad.2015.12.037 DOI: https://doi.org/10.1016/j.jaad.2015.12.037
Dreno B, Beylot C, Chivot M, Faure M, Pawin H, Poli F, et al. [An algorithm for the treatment of acne]. Ann Dermatol Venereol 2003; 130: 151–152.
Nonni J. Makeup therapy for scars. In: Téot L, Mustoe TA, Middelkoop E, Gauglitz GG, editors. Textbook on scar management: state of the art management and emerging technologies. Cham: Springer, 2020. p. 435–440.
https://doi.org/10.1007/978-3-030-44766-3_49 DOI: https://doi.org/10.1007/978-3-030-44766-3_49
Piquero-Casals J, Morgado-Carrasco D, Rozas-Muñoz E, Mir-Bonafé JF, Trullàs C, Jourdan E, et al. Sun exposure, a relevant exposome factor in acne patients and how photoprotection can improve outcomes. J Cosmet Dermatol 2023; 22: 1919–1928.
https://doi.org/10.1111/jocd.15726 DOI: https://doi.org/10.1111/jocd.15726
Dréno B, Gallo RL, Berardesca E, Griffiths CEM. Advocacy for a shared physician/patient approach for the management of acne, rosacea, seborrheic dermatitis and photodamage. Eur J Dermatol 2022; 32: 138–139.
https://doi.org/10.1684/ejd.2022.4236 DOI: https://doi.org/10.1684/ejd.2022.4236
Callender VD, St Surin-Lord S, Davis EC, Maclin M. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol 2011; 12: 87–99.
https://doi.org/10.2165/11536930-000000000-00000 DOI: https://doi.org/10.2165/11536930-000000000-00000
Lindgren AL, Austin AH, Welsh KM. The use of tranexamic acid to prevent and treat post-inflammatory hyperpigmentation. J Drugs Dermatol 2021; 20: 344–345.
https://doi.org/10.36849/JDD.5622 DOI: https://doi.org/10.36849/JDD.5622
Draelos ZD. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther 2007; 20: 308–313.
https://doi.org/10.1111/j.1529-8019.2007.00144.x DOI: https://doi.org/10.1111/j.1529-8019.2007.00144.x
Published
How to Cite
License
Copyright (c) 2025 Nicole Auffret, Marie-Thérèse Leccia, Fabienne Ballanger, Jean Paul Claudel, Serge Dahan, Brigitte Dréno
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
